479 related articles for article (PubMed ID: 24108083)
41. Anti-NMDA-receptor encephalitis during pregnancy: A case report and literature review.
Xiao X; Gui S; Bai P; Bai Y; Shan D; Hu Y; Bui-Nguyen TM; Zhou R
J Obstet Gynaecol Res; 2017 Apr; 43(4):768-774. PubMed ID: 28418206
[TBL] [Abstract][Full Text] [Related]
42. [Autoimmune encephalitis as a cause of psychosis].
Suokas K; Kampman O
Duodecim; 2014; 130(5):469-74. PubMed ID: 24730197
[TBL] [Abstract][Full Text] [Related]
43. Schizophrenia after remission of anti-NMDA receptor encephalitis.
Yasuda K; Uenishi S; Sakamoto H; Hori K; Koh J; Takahashi S
Asian J Psychiatr; 2022 Apr; 70():103027. PubMed ID: 35180463
[TBL] [Abstract][Full Text] [Related]
44. Catatonia in Adolescence: First Onset Psychosis or Anti-NMDAr Encephalitis?
Averna R; Battaglia C; Labonia M; Riccioni A; Vicari S
Clin Neuropharmacol; 2019; 42(4):136-138. PubMed ID: 31157633
[TBL] [Abstract][Full Text] [Related]
45. Pediatric anti-NMDA (N-methyl D-aspartate) receptor encephalitis.
Salvucci A; Devine IM; Hammond D; Sheth RD
Pediatr Neurol; 2014 May; 50(5):507-10. PubMed ID: 24656207
[TBL] [Abstract][Full Text] [Related]
46. Anti-N-Methyl-d-Aspartate Receptor Encephalitis Appearing as a New-Onset Psychosis: Disease Course in Children and Adolescents Within the California Encephalitis Project.
Gable M; Glaser C
Pediatr Neurol; 2017 Jul; 72():25-30. PubMed ID: 28506504
[TBL] [Abstract][Full Text] [Related]
47. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
[TBL] [Abstract][Full Text] [Related]
48. Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
Jaka S; Singh S; Vashist S; Pokhrel S; Saldana E; Sejdiu A; Taneja S; Arisoyin A; Mogallapu R; Gunturu S; Bachu A; Patel RS
PLoS One; 2024; 19(2):e0296870. PubMed ID: 38349905
[TBL] [Abstract][Full Text] [Related]
49. Brain on fire: anti-N-methyl-D-aspartate-receptor encephalitis associated with ovarian teratoma.
Maraka S; Bulathsinghala CP; Grover P
Conn Med; 2013 Aug; 77(7):389-92. PubMed ID: 24195175
[TBL] [Abstract][Full Text] [Related]
50. Catatonia in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Misdiagnosed as Schizophrenia.
Ponte A; Brito A; Nóbrega C; Pinheiro S; Gama Marques J
Acta Med Port; 2020 Mar; 33(3):208-211. PubMed ID: 32130101
[TBL] [Abstract][Full Text] [Related]
51. Anti-N-methyl-D-aspartate encephalitis - a case study of symptomatic progression.
Bowes E; Levy F; Lawson J; Mandalis A; Mohan A; Shannon Weickert C
Australas Psychiatry; 2015 Aug; 23(4):422-5. PubMed ID: 26023167
[TBL] [Abstract][Full Text] [Related]
52. Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management.
Kruse JL; Jeffrey JK; Davis MC; Dearlove J; IsHak WW; Brooks JO
Ann Clin Psychiatry; 2014 May; 26(2):111-9. PubMed ID: 24501734
[TBL] [Abstract][Full Text] [Related]
53. Biological Perspectives: Anti-NMDA Receptor Encephalitis.
Dowben JS; Kowalski PC; Keltner NL
Perspect Psychiatr Care; 2015 Oct; 51(4):236-40. PubMed ID: 26220456
[TBL] [Abstract][Full Text] [Related]
54. Anti-NMDA receptor encephalitis presenting with total insomnia--a case report.
Marques IB; Teotónio R; Cunha C; Bento C; Sales F
J Neurol Sci; 2014 Jan; 336(1-2):276-80. PubMed ID: 24210076
[TBL] [Abstract][Full Text] [Related]
55. Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report.
Appu M; Noetzel M
Pediatr Neurol; 2014 Mar; 50(3):262-4. PubMed ID: 24417935
[TBL] [Abstract][Full Text] [Related]
56. The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms.
Hinotsu K; Miyaji C; Yada Y; Kawai H; Sakamoto S; Okahisa Y; Tsutsui K; Kanbayashi T; Tanaka K; Takao S; Kishi Y; Takaki M; Yamada N
Schizophr Res; 2022 Oct; 248():292-299. PubMed ID: 36130472
[TBL] [Abstract][Full Text] [Related]
57. Anti-NMDAR encephalitis misdiagnosed as Hashimoto's encephalopathy.
Mirabelli-Badenier M; Biancheri R; Morana G; Fornarino S; Siri L; Celle ME; Veneselli E; Vincent A; Gaggero R; Mancardi MM
Eur J Paediatr Neurol; 2014 Jan; 18(1):72-4. PubMed ID: 23953644
[TBL] [Abstract][Full Text] [Related]
58. Acute psychosis in children: do not miss immune-mediated causes.
AlHakeem AS; Mekki MS; AlShahwan SM; Tabarki BM
Neurosciences (Riyadh); 2016 Jul; 21(3):252-5. PubMed ID: 27356658
[TBL] [Abstract][Full Text] [Related]
59. Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited.
Merwick A; Dalmau J; Delanty N
J Neurol Sci; 2013 Nov; 334(1-2):167-8. PubMed ID: 23927937
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
Kelleher E; McNamara P; Dunne J; Fitzmaurice B; Heron EA; Whitty P; Walsh R; Mooney C; Hogan D; Conlon N; Gill M; Vincent A; Doherty CP; Corvin A
Schizophr Res; 2020 Aug; 222():455-461. PubMed ID: 32499165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
